GPBAR1 and congenital secretory chloride diarrhea 1: Current results suggest that serum LCA levels may be used as a prognostic factor of survival in CLD patients with sarcopenia, and a TGR5 agonist holds the potential to be a candidate as a therapeutic target in the prevention of sarcopenia in CLD patients.